Gujarat Themis Raises Rs 585 Cr, Private Credit For Japan Buyout
The company uses multiple debt sources to finance its acquisition of Japanese pharmaceutical firm MicroBiopharmIndian drugmaker Gujarat Themis Biosyn has secured private credit funding to support its acquisition of Japan-based MicroBiopharm Japan, as companies increasingly use private credit to fin…